3rd Oct 2011 15:55
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 30 September 2011, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £13.40 per Ordinary share and $41.61 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2011 to 30 September 2011:
Non Executive Director | Ordinary Shares | American Depository Shares (ADSs) |
Sir Christopher Gent | 2,518.657 | |
Prof. Sir Roy Anderson | 489.739 | |
498.315 | ||
Dr Stephanie Burns | ||
Ms Stacey Cartwright | 349.813 | |
Mr Lawrence Culp | 996.629 | |
Sir Crispin Davis | 1,772.388 | |
Ms Judy Lewent | 249.157 | |
Sir Deryck Maughan | 711.878 | |
Mr James Murdoch | 1,399.254 | |
Dr Daniel Podolsky | 961.036 | |
Mr Tom de Swaan | 722.948 | |
Sir Robert Wilson | 489.739 | |
The Company and the Non-Executive Directors were informed of these allocations on 3 October 2011.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
3 October 2011
Related Shares:
Glaxosmithkline